Magee Thomson Investment Partners’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$1K Sell
89
-11
-11% -$112 ﹤0.01% 33
2016
Q4
$1K Sell
100
-27
-21% -$233 ﹤0.01% 42
2016
Q3
$1K Sell
127
-98
-44% -$797 ﹤0.01% 38
2016
Q2
$2K Sell
225
-755
-77% -$4.27K ﹤0.01% 27
2016
Q1
$5K Buy
980
+126
+15% +$640 ﹤0.01% 33
2015
Q4
$4K Sell
854
-351
-29% -$1.74K ﹤0.01% 77
2015
Q3
$5K Sell
1,205
-500
-29% -$2K ﹤0.01% 44
2015
Q2
$5K Hold
1,705
﹤0.01% 54
2015
Q1
$5K Hold
1,705
﹤0.01% 54
2014
Q4
$5K Buy
+1,705
New +$4.99K ﹤0.01% 114

Other funds holding AXGN

Magee Thomson Investment Partners's AXGN Position: Q1 2017 in Review

Magee Thomson Investment Partners reduced its Axogen (AXGN) stake by 11% in Q1 2017, selling an estimated $112 and leaving 89 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #33.

Magee Thomson Investment Partners first reported a position in AXGN in Q4 2014 and has held it in 10 quarters since. The position peaked at $5K in Q1 2016. 92 funds tracked by Wall St. Rank hold AXGN as of Q1 2017.

  • Magee Thomson Investment Partners held 89 shares of Axogen worth $1K as of Q1 2017.
  • Magee Thomson Investment Partners sold 11 Axogen shares in Q1 2017, an estimated $112.
  • Axogen made up ﹤0.01% of Magee Thomson Investment Partners's portfolio in Q1 2017, its #33 holding.
  • Magee Thomson Investment Partners first reported a position in Axogen in Q4 2014 and has held it in 10 quarters since.
  • Magee Thomson Investment Partners's Axogen position peaked at $5K in Q1 2016.
  • 92 funds tracked by Wall St. Rank held Axogen as of Q1 2017.

Based on Magee Thomson Investment Partners's 13F filing for Q1 2017, filed 21 Apr 2017.